お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:除細動器の世界市場:エンドユーザー、製品、地理別の成長率、動向および予測
市場調査レポート
商品コード
659348

除細動器の世界市場:エンドユーザー、製品、地理別の成長率、動向および予測

Defibrillator Market - Growth, Trends, and Forecasts (2020 - 2025)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 110 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=112.06円
除細動器の世界市場:エンドユーザー、製品、地理別の成長率、動向および予測
出版日: 2020年08月01日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 110 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の除細動器市場は、2018年から2023年の予測期間中に、6.5%のCAGRで成長する見通しです。除細動器は、心室細動、心不整脈、および無脈性心室頻拍などのような命に関わる状態にある患者の心臓に、治療上のショックを与えるのに役立つ救命具です。米国では、毎年約30万人の院外心停止が発生しています。先進国の政府の支援政策は、除細動器の可用性とアクセスを向上させ、予測期間中の市場成長をさらに促進する可能性があります。

当レポートでは、世界の除細動器市場を調査し、全体的な市場動向、製品・地域別の詳細動向、市場成長への影響要因の分析、競合情勢、主要企業のプロファイルなどを包括的にまとめています。

目次

第1章 イントロダクション

  • 市場の定義

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 主な予測

第5章 市場の概要

  • 現在の市場シナリオ
  • パイプライン分析
  • ポーターのファイブフォース分析
    • サプライヤーの交渉力
    • 消費者の交渉力
    • 新規参入の脅威
    • 代替製品とサービスの脅威
    • 業界内での競争
  • 規制のシナリオ

第6章 成長要因、阻害要因、機会、課題の分析(DROC)

  • 市場の成長要因
    • 増加している心臓血管疾患の罹患率
    • 除細動器の技術進歩
    • 除細動器のトレーニングと啓蒙活動
  • 市場の阻害要因
    • コストの高い除細動器
    • 厳格な規制枠組み
  • 市場機会
  • 主な課題

第7章 市場セグメンテーション

  • エンドユーザー別
    • 病院
    • 救急医療
    • 在宅医療
    • その他
  • 製品別
    • 埋め込み型除細動器(ICD)
    • 体外除細動器(ED)
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第8章 競合情勢

  • M&A分析
  • 合意、コラボレーション、パートナーシップ
  • 新製品の発売

第9章 主要プレーヤー

  • Boston Scientific Corporation
  • Cardiac Science
  • Defibtech LLC
  • Koninklijke Philips NV
  • LivaNova PLC
  • Medtronic
  • 日本光電
  • Physio-Control Inc.
  • Abbott (St. Jude Medical, LLC)
  • ZOLL Medical Corporation

第10章 市場の将来展望

目次
Product Code: 61708

The growth of the defibrillator market can be attributed to factors, such as technological advancements in the field of defibrillators and training and awareness programs for defibrillators. Recently, in 2020, Abbott Laboratories received a CE mark for its product "Gallant". It is an implantable cardioverter defibrillator (ICD) used in the prevention of sudden cardiac rhythm. Furthermore, the growing burden of cardiovascular diseases is expected to impact market growth.

According to the World Health Organization, in 2017, cardiovascular diseases were the leading cause of death, causing around 17.9 million deaths every year, globally. Hence, the increase in the prevalence of cardiovascular diseases is expected to drive market growth.

In the United States, approximately 300,000 out-of-hospital cardiac arrests occur, annually. Supportive government policies in developed countries may help increase the availability and access of defibrillators, which may further boost the market growth, over the forecast period.

Key Market Trends

Implantable Cardioverter Defibrillator (ICD) Spearheaded the Market Studied

  • The implantable cardioverter defibrillator (ICD) segment accounted for the largest share in the global market. The ICDs are of three major types, namely transvenous ICDs, subcutaneous ICDs, and CRT with pacemaker and ICD function.
  • The transvenous and subcutaneous ICDs are expected to exhibit the fastest growth rate over the forecast period, owing to the rising technological advancements, increasing R&D, and benefits associated with these ICDs. According to the European Heart Journal, 2019, implantable cardioverter-defibrillator (ICD) is considered as an important device for the treatment of sudden cardiac death (SCD) prevention and ventricular tachyarrhythmias.
  • Moreover, according to the Australian Institute of Health and Welfare, in 2017, approximately 4,578 people died, due to heart failure and cardiomyopathy. Hence, the growing morbidity and mortality of cardiovascular diseases and the efficacy of these devices to manage arrhythmias for a prolonged period are expected to drive the segment's growth, over the forecast period.

North America is Expected to Dominate the Market Studied

  • In North America, the United States is expected to hold the major market share. This is mainly due to factors, such as increasing number of diseases.
  • Cardiovascular diseases, listed as the underlying cause of death, account for nearly 836,546 deaths (about 1 of every 3 deaths) in the United States. The increasing prevalence of cardiovascular diseases in the region is expected to drive the market growth, over the forecast period.
  • In 2017, the Department of Health and Human Services (HHS), along with a number of public and private partners, launched the Million Hearts initiative that aims to prevent one million heart attacks and strokes.
  • According to the American Heart Association's research program, cardiovascular diseases are listed as the primary cause of deaths and accounted for nearly 836,546 deaths in the United States. The deaths related to cardiovascular diseases are higher when compared to deaths related to all forms of cancer and chronic lower respiratory diseases combined.
  • Therefore, the aforementioned factors are expected to boost the market growth.

Competitive Landscape

The major players operating in the defibrillators market are Boston Scientific Corporation, Koninklijke Philips NV, Medtronic PLC, Nihon Kohden Corporation, and Abbott Laboratories. The key strategies adopted by the major market players are mergers, acquisitions, new product developments, geographical expansions, and enhanced marketing strategies.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Cardiovascular Diseases
    • 4.2.2 Technological Advancements in the Field of Defibrillators
  • 4.3 Market Restraints
    • 4.3.1 High Costs of Defibrilators
    • 4.3.2 Stringent Regulatory Framework
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Implantable Cardioverter Defibrillator (ICD)
      • 5.1.1.1 Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
      • 5.1.1.2 Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
      • 5.1.1.3 CRT with Pacemaker and ICD Function (CRT-D)
    • 5.1.2 External Defibrillator (ED)
      • 5.1.2.1 Automated External Defibrillator (AEDs)
      • 5.1.2.1.1 Semi-automated External Defibrillators
      • 5.1.2.1.2 Fully-automated External Defibrillators
      • 5.1.2.2 Manual External Defibrillator
      • 5.1.2.3 Wearable Cardioverter Defibrillators (WCDs)
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Emergency Care
    • 5.2.3 Home Care
    • 5.2.4 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 United Kingdom
      • 5.3.2.2 Germany
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 Cardiac Science Corporation
    • 6.1.4 Defibtech LLC
    • 6.1.5 Koninklijke Philips NV
    • 6.1.6 LivaNova PLC
    • 6.1.7 Medtronic PLC
    • 6.1.8 Nihon Kohden Corporation
    • 6.1.9 Physio-Control Inc.
    • 6.1.10 ZOLL Medical Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.